BACKGROUND: An adequate maternal iron supply is crucial for maternal red blood cell (RBC) expansion, placental and fetal growth, and fetal brain development. Obese women may be at risk for poor iron status in pregnancy due to proinflammatory-driven overexpression of hepcidin leading to decreased iron bioavailability. OBJECTIVE: The objective of this study was to determine the impact of prepregnancy (PP) obesity on third-trimester maternal iron utilization. DESIGN: Using the stable isotope 57Fe, we measured iron utilization in the third trimester in PP obese [BMI (in kg/m2): ≥30] and nonobese (BMI: 18.5-29.9) women. We also assessed iron status, hepcidin, inflammation, erythropoietin, dietary iron intake, and gestational weight gain. Descriptive and inferential statistical tests (e.g., Student t test, Pearson correlation) were used for data analysis. RESULTS: Fifty pregnant women (21 PP obese, 29 PP nonobese) were included. Mean age was 27.6 ± 6.8 y and mean gestational age at time of 57Fe administration was 32.7 ± 0.7 wk. Anemia (hemoglobin <11 g/dL for non-black and <10.2 g/dL for black women) affected 38% of women (43% PP obese compared with 35% PP nonobese; P = 0.55). Women with PP obesity had significantly higher C-reactive protein (8.5 compared with 3.4 mg/L, P = 0.0007) and total body iron corrected for inflammation (6.0 compared with 4.3 mg/kg, P = 0.04) compared with the nonobese women. There was no difference in serum hepcidin or iron utilization between the PP BMI groups. CONCLUSION: This is the first study to assess the impact of PP obesity on maternal iron utilization. We found no difference in iron utilization in the third trimester of pregnancy in women with and without PP obesity. Despite higher frequency of anemia, women with PP obesity had less depleted body iron stores, suggesting some degree of iron sequestration. This finding should be followed up and extended to understand effects on fetal iron bioavailability.
BACKGROUND: An adequate maternal iron supply is crucial for maternal red blood cell (RBC) expansion, placental and fetal growth, and fetal brain development. Obesewomen may be at risk for poor iron status in pregnancy due to proinflammatory-driven overexpression of hepcidin leading to decreased iron bioavailability. OBJECTIVE: The objective of this study was to determine the impact of prepregnancy (PP) obesity on third-trimester maternal iron utilization. DESIGN: Using the stable isotope 57Fe, we measured iron utilization in the third trimester in PP obese [BMI (in kg/m2): ≥30] and nonobese (BMI: 18.5-29.9) women. We also assessed iron status, hepcidin, inflammation, erythropoietin, dietary iron intake, and gestational weight gain. Descriptive and inferential statistical tests (e.g., Student t test, Pearson correlation) were used for data analysis. RESULTS: Fifty pregnant women (21 PP obese, 29 PP nonobese) were included. Mean age was 27.6 ± 6.8 y and mean gestational age at time of 57Fe administration was 32.7 ± 0.7 wk. Anemia (hemoglobin <11 g/dL for non-black and <10.2 g/dL for black women) affected 38% of women (43% PP obese compared with 35% PP nonobese; P = 0.55). Women with PP obesity had significantly higher C-reactive protein (8.5 compared with 3.4 mg/L, P = 0.0007) and total body iron corrected for inflammation (6.0 compared with 4.3 mg/kg, P = 0.04) compared with the nonobese women. There was no difference in serum hepcidin or iron utilization between the PP BMI groups. CONCLUSION: This is the first study to assess the impact of PP obesity on maternal iron utilization. We found no difference in iron utilization in the third trimester of pregnancy in women with and without PP obesity. Despite higher frequency of anemia, women with PP obesity had less depleted body iron stores, suggesting some degree of iron sequestration. This finding should be followed up and extended to understand effects on fetal iron bioavailability.
Authors: Mari Rehu; Kari Punnonen; Vaughn Ostland; Seppo Heinonen; Mark Westerman; Kari Pulkki; Ulla Sankilampi Journal: Eur J Haematol Date: 2010-07-22 Impact factor: 2.997
Authors: Elizabeta Nemeth; Erika V Valore; Mary Territo; Gary Schiller; Alan Lichtenstein; Tomas Ganz Journal: Blood Date: 2002-11-14 Impact factor: 22.113
Authors: S J Fomon; E E Ziegler; R R Rogers; S E Nelson; B B Edwards; D G Guy; J C Erve; M Janghorbani Journal: Pediatr Res Date: 1989-09 Impact factor: 3.756
Authors: L Garcia-Valdes; C Campoy; H Hayes; J Florido; I Rusanova; M T Miranda; H J McArdle Journal: Int J Obes (Lond) Date: 2015-01-23 Impact factor: 5.095
Authors: Lisa M Tussing-Humphreys; Elizabeta Nemeth; Giamila Fantuzzi; Sally Freels; Ai-xuan L Holterman; Carlos Galvani; Subhashini Ayloo; Joseph Vitello; Carol Braunschweig Journal: Obesity (Silver Spring) Date: 2010-01-14 Impact factor: 5.002
Authors: Fabian Rohner; Sorrel Ml Namaste; Leila M Larson; O Yaw Addo; Zuguo Mei; Parminder S Suchdev; Anne M Williams; Fayrouz A Sakr Ashour; Rahul Rawat; Daniel J Raiten; Christine A Northrop-Clewes Journal: Am J Clin Nutr Date: 2017-06-14 Impact factor: 7.045
Authors: Zuguo Mei; Sorrel Ml Namaste; Mary Serdula; Parminder S Suchdev; Fabian Rohner; Rafael Flores-Ayala; O Yaw Addo; Daniel J Raiten Journal: Am J Clin Nutr Date: 2017-06-14 Impact factor: 7.045
Authors: Katherine M Delaney; Chang Cao; Ronnie Guillet; Eva K Pressman; Kimberly O O'Brien Journal: Am J Clin Nutr Date: 2022-04-01 Impact factor: 8.472
Authors: Reyna Sámano; Gabriela Chico-Barba; María Eugenia Flores-Quijano; Estela Godínez-Martínez; Hugo Martínez-Rojano; Luis Ortiz-Hernandez; Oralia Nájera-Medina; María Hernández-Trejo; Cristopher Hurtado-Solache Journal: Int J Environ Res Public Health Date: 2021-12-28 Impact factor: 3.390
Authors: Nicole U Stoffel; Michael B Zimmermann; Ana C Cepeda-Lopez; Karla Cervantes-Gracia; Daniel Llanas-Cornejo; Christophe Zeder; Siriporn Tuntipopipat; Sakita Moungmaithong; Narumon Densupsoontorn; Katharina Quack Loetscher; Sueppong Gowachirapant; Isabelle Herter-Aeberli Journal: Am J Clin Nutr Date: 2022-04-01 Impact factor: 7.045
Authors: Benjamin A Turturice; Juliana Theorell; Mary Dawn Koenig; Lisa Tussing-Humphreys; Diane R Gold; Augusto A Litonjua; Emily Oken; Sheryl L Rifas-Shiman; David L Perkins; Patricia W Finn Journal: Elife Date: 2021-02-10 Impact factor: 8.140